{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:19:52Z","timestamp":1767849592257,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.rmed.2020.105956","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:01:35Z","timestamp":1586304095000},"page":"105956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and\/or delamanid in South Korea"],"prefix":"10.1016","volume":"167","author":[{"given":"Hyungseok","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Wook","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doosoo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Joon","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Sun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2020.105956_bib1","author":"WHO"},{"key":"10.1016\/j.rmed.2020.105956_bib2","first-page":"401","article-title":"Tuberculosis notification status in Korea in 2017","volume":"11","author":"Park","year":"2018","journal-title":"Public Health Wkly Rep"},{"key":"10.1016\/j.rmed.2020.105956_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5588\/ijtld.14.0739","article-title":"Changes in treatment outcomes of multidrug-resistant tuberculosis","volume":"19","author":"Kwak","year":"2015","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.rmed.2020.105956_bib4","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1093\/jac\/dkv215","article-title":"Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment","volume":"70","author":"Jeong","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rmed.2020.105956_bib5","author":"Korea Centers for Disease Control & Prevention"},{"key":"10.1016\/j.rmed.2020.105956_bib6","author":"WHO"},{"key":"10.1016\/j.rmed.2020.105956_bib7","author":"WHO"},{"key":"10.1016\/j.rmed.2020.105956_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2213-2600(18)30426-0","article-title":"Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial","volume":"7","author":"von Groote-Bidlingmaier","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.rmed.2020.105956_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02467-2017","article-title":"Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea","volume":"51","author":"Kim","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105956_bib10","article-title":"Clinical outcomes among patients with drug-resistant tuberculosis receiving bedaquiline or delamanid containing regimens","author":"Kempker","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2020.105956_bib11","author":"WHO"},{"key":"10.1016\/j.rmed.2020.105956_bib12","unstructured":"DR-TB STAT. Available at:: drtb-stat.org\/wp-content\/uploads\/2018\/05\/DR-TB-STAT-May-2018-Global-Summary.pdf Accessed November 30 2018."},{"issue":"2","key":"10.1016\/j.rmed.2020.105956_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00537-2018","article-title":"QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a tuberculosis network european trials group (TBnet) study","volume":"52","author":"Guglielmetti","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105956_bib15","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1164\/rccm.201801-0019LE","article-title":"Bedaquiline and repurposed drugs for fluoroquinolone-resistant multidrug-resistant tuberculosis: how much better are they?","volume":"198","author":"Bastard","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2020.105956_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00544-2018","article-title":"Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa","volume":"51","author":"Olayanju","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105956_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(18)30235-2","article-title":"Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study","volume":"6","author":"Schnippel","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.rmed.2020.105956_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00017-2018","article-title":"Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa","volume":"51","author":"Mohr","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2020.105956_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00811-2019","article-title":"Final treatment outcomes of delamanid-containing regimens in patients with MDR-\/XDR-TB in South Korea","volume":"54","author":"Mok","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105956_bib21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1164\/rccm.200801-132OC","article-title":"Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis","volume":"178","author":"Kim","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2020.105956_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1186\/s12879-018-3574-y","article-title":"Treatment outcomes and factors affecting treatment outcomes of new patients with tuberculosis in Busan, South Korea: a retrospective study of a citywide registry, 2014-2015","volume":"18","author":"Mok","year":"2018","journal-title":"BMC Infect. Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120300962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120300962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:58:53Z","timestamp":1760615933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120300962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":20,"alternative-id":["S0954611120300962"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105956","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and\/or delamanid in South Korea","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105956"}}